Are insiders buying or selling uniQure N.V. stock?

Based on the last 50 SEC Form 4 filings, uniQure N.V. insiders made 0 open-market purchases and 26 open-market sales.

Where can I see uniQure N.V. insider trading activity?

SEC Form 4 filings for uniQure N.V. (QURE) are publicly available on EDGAR and aggregated at form4api.com/companies/qure.

Company profile

uniQure N.V. Insider Trading

Name: uniQure N.V. Insider Trading Data
Creator: Form4API
License: https://www.sec.gov/privacy.htm

QURE

Every SEC Form 4 insider trading filing for uniQure N.V. (QURE) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange: Nasdaq
Sector: Pharmaceutical Preparations
CIK: 0001590560
Filings: 102
Insiders: 15
Last filing: 2026-07-02

SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on July 2, 2026, when Matthew C Kapusta sold 9,200 shares. 102 filings from 15 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. uniQure N.V. insiders are net sellers across the period shown.

PurchasesSales

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $17.0M.

90 day insight

Over the last 90 days, uniQure N.V. insiders sold $67K across 1 transaction with no open-market purchases.

Most active insider: Matthew C Kapusta with 11 transactions totaling $4.2M.
Largest single sale: $1.4M by Matthew C Kapusta on Jun 25, 2026.
90% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bearish — sales outpace buys.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

Date	Insider	Company	Type	Shares	Price	Value	Return
Jul 2, 2026	Matthew C Kapusta	QURE	Sale10b5	9,200	$44.43	$409K	+9.2% 1m
Jul 2, 2026	Matthew C Kapusta	QURE	Sale10b5	7,600	$45.89	$349K	+9.2% 1m
Jul 2, 2026	Matthew C Kapusta	QURE	Option Exercise10b5	21,082	—	—	+9.2% 1m
Jul 2, 2026	Matthew C Kapusta	QURE	Option Exercise10b5	21,082	$19.39	$409K	+9.2% 1m
Jul 2, 2026	Matthew C Kapusta	QURE	Sale10b5	4,282	$45.43	$195K	+9.2% 1m

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=QURE" \
  -H "X-Api-Key: $KEY"

Get a key

Top insiders

By total value filed.

Matthew C KapustaCEO, Managing Director18 filings−$9.3M

Jack KayeDirector6 filings−$544K

Walid Abi-SaabChief Medical Officer4 filings−$1.4M

Madhavan Balachandran7 filings−$428K

Kylie O'KeefeChief Customer & Strat Officer1 filing−$431K